28 COVID-19 Therapeutics and 11 Vaccines Approved for Clinical Trials in Korea

[Image source=Yonhap News]

[Asia Economy Reporter Jo In-kyung] The Ministry of Food and Drug Safety announced on the 28th that a total of 39 items have been approved for clinical trials so far, including 28 COVID-19 treatments and 11 vaccines.

Among the 28 COVID-19 treatments approved for clinical trials, 21 are domestically developed drugs. Of these, clinical trials for 14 items are currently underway, and 7 items have been completed.

There are 7 foreign-developed treatments, of which 3 are currently in the clinical trial phase and 4 have completed clinical trials.

Among the 11 COVID-19 vaccines, 10 are domestically developed and 1 is foreign-developed, all of which are currently undergoing clinical trials.

By platform, there are 5 recombinant vaccines, 3 DNA vaccines, 2 RNA vaccines, and 1 viral vector vaccine.

An official from the Ministry of Food and Drug Safety stated, "We are continuously monitoring the progress of clinical trials for COVID-19 treatments and vaccines and are doing our best to ensure safety management," adding, "We will continue to strive to ensure that clinical trials are conducted safely and promptly."

This content was produced with the assistance of AI translation services.